investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Characterization of the Expression and Ligands of KIR3DS2
Daniel McVicar
5 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Simon Kollnberger
University of Oxford
Oxford, United Kingdom
Jamie Rossjohn
Monash University
Melbourne, Australia
Maria-Luiza Petzl-Erler
Federal University of Paraná
Curitiba, Brazil
David Price
Cardiff University
Cardiff, United Kingdom
Andrew Brooks
University of Melbourne
Melbourne, Australia
Daniel McVicar
National Cancer Institute (NIH)
Rockville, United States
Related projects
Clark W Distelhorst
Targeting PKM2-InsP3R interaction to treat AML
Leukaemia
Hematology and hematologic malignancies
Derrick J. Rossi
Reprogramming committed blood cells to a hematopoietic stem cell fate
Leukaemia
Hematology and hematologic malignancies
Robert Kreitman
Development of Recombinant Toxins to Treat Hematologic Malignancies
Leukaemia
Hematology and hematologic malignancies
Catherine Ju-Ying Wu
Defining the Impact of Clonal Evolution on Chronic Lymphocytic Leukemia
Leukaemia
Hematology and hematologic malignancies
Pathology
Peter Aplan
Collaborative Pathways that Lead to Leukemia
Leukaemia
Hematology and hematologic malignancies
Pathology
Vinay Pathak
Retroviral Replication and Interactions with Host Factors
Leukaemia
Hematology and hematologic malignancies
Pathology
Scott H Kaufmann
Regulation of Death Ligand-Induced Killing
Leukaemia
Hematology and hematologic malignancies
Pathology
Katy Rezvani
Curative Cell-based Therapies for Chronic Lymphocytic Leukemia
Leukaemia
Hematology and hematologic malignancies
David A Williams
Rac proteins in hematopoietic cell survival and function
Leukaemia
Hematology and hematologic malignancies
